MXCT: MaxCyte Inc
MXCT exchange rate has changed by 4.64% for today. During the day, the instrument was traded at a low of 1.48 and at a high of 1.61.
Follow MaxCyte Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
MXCT News
- MaxCyte, Inc. (MXCT) Q3 2025 Earnings Call Transcript
- MaxCyte CFO Douglas Swirsky to step down in first half of 2026
- Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Beats Revenue Estimates
- ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Beat Estimates
- Masoud Maher buys Maxcyte (MXCT) shares worth $102,915
- Maxcyte CFO Swirsky buys $64.5k in shares
- Brooke William buys Maxcyte (MXCT) shares worth $64,500
- Douglas buys $111k in Maxcyte shares
- Erck Stanley C, Maxcyte director, buys $137k in MXCT stock
- This C3.ai Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - C3.ai (NYSE:AI), Aspen Aerogels (NYSE:ASPN)
- MaxCyte stock rating downgraded to Neutral by BTIG on funding concerns
- MaxCyte stock downgraded by William Blair to Market Perform on weak guidance
- MaxCyte, Inc. (MXCT) Reports Q2 Loss, Misses Revenue Estimates
- MaxCyte Q3 2025 presentation slides: SPL portfolio expands despite market challenges
- MaxCyte to delist shares from London AIM, maintains Nasdaq listing
- MaxCyte stockholders approve AIM delisting, company to trade only on Nasdaq
- MaxCyte shareholders approve equity plan expansion, AIM delisting
- MaxCyte and Ori Biotech partner to enhance cell therapy manufacturing
- MaxCyte: Strong Revenues, Fast-Growing Cell-Therapy Market (NASDAQ:MXCT)
- Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Lazard (NYSE:LAZ), Amylyx Pharmaceuticals (NASDAQ:AMLX)
- MaxCyte, Inc. (MXCT) Q4 2024 Earnings Call Transcript
- MaxCyte shares tumble as Q4 revenue plunges despite beating estimates
Frequently Asked Questions
What is MXCT stock price today?
MaxCyte Inc stock is priced at 1.58 today. It trades within 1.48 - 1.61, yesterday's close was 1.51, and trading volume reached 512. The live price chart of MXCT shows these updates.
Does MaxCyte Inc stock pay dividends?
MaxCyte Inc is currently valued at 1.58. Dividend policy depends on the company, while investors also watch -55.62% and USD. View the chart live to track MXCT movements.
How to buy MXCT stock?
You can buy MaxCyte Inc shares at the current price of 1.58. Orders are usually placed near 1.58 or 1.88, while 512 and 6.04% show market activity. Follow MXCT updates on the live chart today.
How to invest into MXCT stock?
Investing in MaxCyte Inc involves considering the yearly range 1.29 - 5.20 and current price 1.58. Many compare 2.60% and -32.77% before placing orders at 1.58 or 1.88. Explore the MXCT price chart live with daily changes.
What are MAXCYTE, INC. stock highest prices?
The highest price of MAXCYTE, INC. in the past year was 5.20. Within 1.29 - 5.20, the stock fluctuated notably, and comparing with 1.51 helps spot resistance levels. Track MaxCyte Inc performance using the live chart.
What are MAXCYTE, INC. stock lowest prices?
The lowest price of MAXCYTE, INC. (MXCT) over the year was 1.29. Comparing it with the current 1.58 and 1.29 - 5.20 shows potential long-term entry points. Watch MXCT moves on the chart live for more details.
When did MXCT stock split?
MaxCyte Inc has gone through stock splits historically. These changes are visible in , 1.51, and -55.62% after corporate actions.
- Previous Close
- 1.51
- Open
- 1.49
- Bid
- 1.58
- Ask
- 1.88
- Low
- 1.48
- High
- 1.61
- Volume
- 512
- Daily Change
- 4.64%
- Month Change
- 2.60%
- 6 Months Change
- -32.77%
- Year Change
- -55.62%